• No results found

Patient reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial

N/A
N/A
Protected

Academic year: 2020

Share "Patient reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial"

Copied!
10
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1 PRO scores over time for (A) PtGA, (B) Pain, (C) HAQ-DI, (D) FACIT-F, (E) SF-36 PCS and (F) SF-36 MCS (FAS)
Figure 2 Proportion of patients reporting improvements ≥MCID in (A) PtGA, (B) Pain, (C) HAQ-DI, (D) FACIT-F,  tofacitinib+MTX versus ADA+MTX
Figure 3 The proportion of patients reporting (A) Pain scores <20 mm over time, and (B) ≥20%, 30%, 50% or 70% improvements in Pain at month 6 (FAS)
Figure 4 Spydergrams representing mean SF-36 domain scores over time for (A) tofacitinib 5 mg two times per day,  (B) tofacitinib 5 mg two times per day+MTX and (C) ADA+MTX

References

Related documents

The Recovery model of support for mental health service users is at the forefront of user led services, and should be the working model for further supported tenancies in

The inspector was satisfied that the quality of care and experience of the residents was monitored and developed on an ongoing basis and that effective management systems are in

This study identified, the interest of operators to increase trust and speed of information flow in the supply chain, the source of produce/product- homegrown and /or

Our results showed that activation of ER stress by tunica- mycin counteracted the inhibitory effects of GB on cTnI and cTnT levels and apoptosis index, verifying our conclusion

The quantitative data on the a-ketonic steroid pattern in male urine are found in Table I. Sub- jects are listed by initial and in ascending order of age, with hydrolytic method,

underlying hypertensive cardiovascular disease, the present study was undertaken to compare the extracellular fluid volume in experimental and hu- man hypertension with that of

Oxygen content, capacity, and percentage saturation of bone marrow blood were determined in man in a group of controls and in patients with polycythemia vera, anemia, and anoxic

The fact that adrenocorticotrophic hormone did not cause as great a rise in the excretion of neutral reducing lipids in the cases of adrenal hyperplasia with virilism as it did in